{
  "solution_stats": {
    "total_solutions": 5,
    "details": [
      {
        "solution_id": 1,
        "steps_count": 7
      },
      {
        "solution_id": 2,
        "steps_count": 7
      },
      {
        "solution_id": 3,
        "steps_count": 11
      },
      {
        "solution_id": 4,
        "steps_count": 5
      },
      {
        "solution_id": 5,
        "steps_count": 12
      }
    ]
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule35",
              "prover9": "(-(A6 -> -A5) -> A8)",
              "prover9_expression": "(-(compound_safe(drug_alpha) -> -compound_toxic(drug_alpha)) -> phase1_completed(drug_alpha))",
              "natural": "Under the condition that it is not the case that whenever drug Alpha's compound is safe, then drug Alpha's compound is not toxic, then drug Alpha completes Phase 1."
            },
            {
              "id": "Rule27",
              "prover9": "(A8 -> A7)",
              "prover9_expression": "(phase1_completed(drug_alpha) -> clinical_trial_approved(drug_alpha))",
              "natural": "Whenever drug Alpha completes Phase 1, then the clinical trial is approved for drug Alpha."
            }
          ],
          "conclusion": "(-(A6 -> -A5) -> A7)",
          "natural": "Provided that it is not the case that if drug Alpha's compound is safe, then it is not the case that drug Alpha's compound is toxic, then the clinical trial is approved for drug Alpha."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A6 -> -A5) -> A7)",
              "prover9_expression": "(-(compound_safe(drug_alpha) -> -compound_toxic(drug_alpha)) -> clinical_trial_approved(drug_alpha))",
              "natural": "Provided that it is not the case that if drug Alpha's compound is safe, then it is not the case that drug Alpha's compound is toxic, then the clinical trial is approved for drug Alpha."
            },
            {
              "id": "Fact7",
              "prover9": "-A7",
              "prover9_expression": "-clinical_trial_approved(drug_alpha)",
              "natural": "The clinical trial is not approved for drug Alpha."
            }
          ],
          "conclusion": "(A6 -> -A5)",
          "natural": "Under the condition that drug Alpha's compound is safe, then it is not the case that drug Alpha's compound is toxic."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule34",
              "prover9": "(-(A4 -> (-G -> -A1)) -> A6)",
              "prover9_expression": "(-(in_vitro_tests_passed(drug_alpha) -> (-global_health_priority(influenza_x) -> -side_effect_severe(drug_alpha))) -> compound_safe(drug_alpha))",
              "natural": "If it is not the case that provided in-vitro tests are passed for drug Alpha, then under the condition that influenza X is not a global health priority, then drug Alpha does not have severe side effects, then drug Alpha's compound is safe."
            },
            {
              "id": "Derived",
              "prover9": "(A6 -> -A5)",
              "prover9_expression": "(compound_safe(drug_alpha) -> -compound_toxic(drug_alpha))",
              "natural": "Under the condition that drug Alpha's compound is safe, then it is not the case that drug Alpha's compound is toxic."
            }
          ],
          "conclusion": "(-(A4 -> (-G -> -A1)) -> -A5)",
          "natural": "Whenever it is not the case that if in-vitro tests are passed for drug Alpha, then if it is not the case that influenza X is a global health priority, then drug Alpha does not have severe side effects, then it is not the case that drug Alpha's compound is toxic."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule33",
              "prover9": "(-(A4 -> (-G -> -A1)) -> A5)",
              "prover9_expression": "(-(in_vitro_tests_passed(drug_alpha) -> (-global_health_priority(influenza_x) -> -side_effect_severe(drug_alpha))) -> compound_toxic(drug_alpha))",
              "natural": "Under the condition that it is not the case that if in-vitro tests are passed for drug Alpha, then provided it is not the case that influenza X is a global health priority, then drug Alpha does not have severe side effects, then drug Alpha's compound is toxic."
            },
            {
              "id": "Derived",
              "prover9": "(-(A4 -> (-G -> -A1)) -> -A5)",
              "prover9_expression": "(-(in_vitro_tests_passed(drug_alpha) -> (-global_health_priority(influenza_x) -> -side_effect_severe(drug_alpha))) -> -compound_toxic(drug_alpha))",
              "natural": "Whenever it is not the case that if in-vitro tests are passed for drug Alpha, then if it is not the case that influenza X is a global health priority, then drug Alpha does not have severe side effects, then it is not the case that drug Alpha's compound is toxic."
            }
          ],
          "conclusion": "(A4 -> (-G -> -A1))",
          "natural": "Provided that in-vitro tests are passed for drug Alpha, then if it is not the case that influenza X is a global health priority, then drug Alpha does not have severe side effects."
        },
        {
          "step_number": 5,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule16",
              "prover9": "(A3 -> A2)",
              "prover9_expression": "(animal_studies_successful(drug_alpha) -> preclinical_tests_passed(drug_alpha))",
              "natural": "Under the condition that animal studies are successful for drug Alpha, then preclinical tests are passed for drug Alpha."
            },
            {
              "id": "Derived",
              "prover9": "(A4 -> (-G -> -A1))",
              "prover9_expression": "(in_vitro_tests_passed(drug_alpha) -> (-global_health_priority(influenza_x) -> -side_effect_severe(drug_alpha)))",
              "natural": "Provided that in-vitro tests are passed for drug Alpha, then if it is not the case that influenza X is a global health priority, then drug Alpha does not have severe side effects."
            },
            {
              "id": "Rule17",
              "prover9": "(A3 | A4)",
              "prover9_expression": "(animal_studies_successful(drug_alpha) | in_vitro_tests_passed(drug_alpha))",
              "natural": "Either animal studies are successful for drug Alpha or in-vitro tests are passed for drug Alpha."
            }
          ],
          "conclusion": "(A2 | (-G -> -A1))",
          "natural": "Either preclinical tests are passed for drug Alpha or, if it is not the case that influenza X is a global health priority, then drug Alpha does not have severe side effects."
        },
        {
          "step_number": 6,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A2 | (-G -> -A1))",
              "prover9_expression": "(preclinical_tests_passed(drug_alpha) | (-global_health_priority(influenza_x) -> -side_effect_severe(drug_alpha)))",
              "natural": "Either preclinical tests are passed for drug Alpha or, if it is not the case that influenza X is a global health priority, then drug Alpha does not have severe side effects."
            },
            {
              "id": "Fact4",
              "prover9": "-A2",
              "prover9_expression": "-preclinical_tests_passed(drug_alpha)",
              "natural": "Drug Alpha did not pass preclinical tests."
            }
          ],
          "conclusion": "(-G -> -A1)",
          "natural": "Under the condition that influenza X is not a global health priority, then drug Alpha does not have severe side effects."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule36",
              "prover9": "(-G -> A1)",
              "prover9_expression": "(-global_health_priority(influenza_x) -> side_effect_severe(drug_alpha))",
              "natural": "Provided that it is not the case that influenza X is a global health priority, then drug Alpha has severe side effects."
            },
            {
              "id": "Derived",
              "prover9": "(-G -> -A1)",
              "prover9_expression": "(-global_health_priority(influenza_x) -> -side_effect_severe(drug_alpha))",
              "natural": "Under the condition that influenza X is not a global health priority, then drug Alpha does not have severe side effects."
            }
          ],
          "conclusion": "G",
          "natural": "Influenza X is a global health priority."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule29",
              "prover9": "(-(A17 -> (A15 -> A13)) -> A19)",
              "prover9_expression": "(-(who_declares_emergency(influenza_x) -> (pandemic_outbreak(influenza_x) -> production_scaled(drug_alpha))) -> stockpile_insufficient(drug_alpha))",
              "natural": "Provided that it is not the case that when WHO declares an emergency for influenza X, then if a pandemic outbreak of influenza X happens, production is scaled for drug Alpha, then drug Alpha's stockpile is insufficient."
            },
            {
              "id": "Fact3",
              "prover9": "-A19",
              "prover9_expression": "-stockpile_insufficient(drug_alpha)",
              "natural": "It is not the case that drug Alpha's stockpile is insufficient."
            }
          ],
          "conclusion": "(A17 -> (A15 -> A13))",
          "natural": "Provided that WHO declares an emergency for influenza X, then if a pandemic outbreak of influenza X happens, production is scaled for drug Alpha."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule7",
              "prover9": "(A17 | A18)",
              "prover9_expression": "(who_declares_emergency(influenza_x) | cdc_declares_emergency(influenza_x))",
              "natural": "Either WHO declares an emergency for influenza X or CDC declares an emergency for influenza X."
            },
            {
              "id": "Derived",
              "prover9": "(A17 -> (A15 -> A13))",
              "prover9_expression": "(who_declares_emergency(influenza_x) -> (pandemic_outbreak(influenza_x) -> production_scaled(drug_alpha)))",
              "natural": "Provided that WHO declares an emergency for influenza X, then if a pandemic outbreak of influenza X happens, production is scaled for drug Alpha."
            },
            {
              "id": "Rule8",
              "prover9": "(A18 -> (A15 -> A13))",
              "prover9_expression": "(cdc_declares_emergency(influenza_x) -> (pandemic_outbreak(influenza_x) -> production_scaled(drug_alpha)))",
              "natural": "If CDC declares an emergency for influenza X, then whenever a pandemic outbreak of influenza X occurs, production is scaled for drug Alpha."
            }
          ],
          "conclusion": "(A15 -> A13)",
          "natural": "Provided that a pandemic outbreak of influenza X happens, then production is scaled for drug Alpha."
        },
        {
          "step_number": 3,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A15 -> A13)",
              "prover9_expression": "(pandemic_outbreak(influenza_x) -> production_scaled(drug_alpha))",
              "natural": "Provided that a pandemic outbreak of influenza X happens, then production is scaled for drug Alpha."
            },
            {
              "id": "Rule6",
              "prover9": "(A16 -> A14)",
              "prover9_expression": "(seasonal_outbreak(influenza_x) -> emergency_approval(drug_alpha))",
              "natural": "Under the condition that a seasonal outbreak occurs for influenza X, then emergency approval occurs for drug Alpha."
            },
            {
              "id": "Rule5",
              "prover9": "(A15 | A16)",
              "prover9_expression": "(pandemic_outbreak(influenza_x) | seasonal_outbreak(influenza_x))",
              "natural": "Either a pandemic outbreak happens for influenza X or a seasonal outbreak happens for influenza X."
            }
          ],
          "conclusion": "(A13 | A14)",
          "natural": "Either production is scaled for drug Alpha or emergency approval occurs for drug Alpha."
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule3",
              "prover9": "(A13 -> A12)",
              "prover9_expression": "(production_scaled(drug_alpha) -> manufacturing_ready(drug_alpha))",
              "natural": "If production is scaled for drug Alpha, then manufacturing is ready for drug Alpha."
            },
            {
              "id": "Rule4",
              "prover9": "(A14 -> (A10 | A11))",
              "prover9_expression": "(emergency_approval(drug_alpha) -> (phase2_successful(drug_alpha) | phase3_successful(drug_alpha)))",
              "natural": "Under the condition that emergency approval occurs for drug Alpha, then either Phase 2 is successful for drug Alpha or Phase 3 is successful for drug Alpha."
            },
            {
              "id": "Derived",
              "prover9": "(A13 | A14)",
              "prover9_expression": "(production_scaled(drug_alpha) | emergency_approval(drug_alpha))",
              "natural": "Either production is scaled for drug Alpha or emergency approval occurs for drug Alpha."
            }
          ],
          "conclusion": "(A12 | (A10 | A11))",
          "natural": "Either manufacturing is ready for drug Alpha, or Phase 2 is successful for drug Alpha, or Phase 3 is successful for drug Alpha."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A12 | (A10 | A11))",
              "prover9_expression": "(manufacturing_ready(drug_alpha) | (phase2_successful(drug_alpha) | phase3_successful(drug_alpha)))",
              "natural": "Either manufacturing is ready for drug Alpha, or Phase 2 is successful for drug Alpha, or Phase 3 is successful for drug Alpha."
            },
            {
              "id": "Fact2",
              "prover9": "-A12",
              "prover9_expression": "-manufacturing_ready(drug_alpha)",
              "natural": "It is not the case that manufacturing is ready for drug Alpha."
            }
          ],
          "conclusion": "(A10 | A11)",
          "natural": "Either Phase 2 is successful for drug Alpha or Phase 3 is successful for drug Alpha."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A10 | A11)",
              "prover9_expression": "(phase2_successful(drug_alpha) | phase3_successful(drug_alpha))",
              "natural": "Either Phase 2 is successful for drug Alpha or Phase 3 is successful for drug Alpha."
            },
            {
              "id": "Rule1",
              "prover9": "(A10 -> A9)",
              "prover9_expression": "(phase2_successful(drug_alpha) -> fda_approved(drug_alpha))",
              "natural": "Provided that Phase 2 is successful for drug Alpha, then FDA approval for drug Alpha occurs."
            },
            {
              "id": "Rule2",
              "prover9": "(A11 -> A9)",
              "prover9_expression": "(phase3_successful(drug_alpha) -> fda_approved(drug_alpha))",
              "natural": "Whenever Phase 3 is successful for drug Alpha, then FDA approval for drug Alpha follows."
            }
          ],
          "conclusion": "A9",
          "natural": "Drug Alpha is FDA-approved."
        },
        {
          "step_number": 7,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule28",
              "prover9": "(A9 -> G)",
              "prover9_expression": "(fda_approved(drug_alpha) -> global_health_priority(influenza_x))",
              "natural": "If drug Alpha is FDA-approved, then influenza X is a global health priority."
            },
            {
              "id": "Derived",
              "prover9": "A9",
              "prover9_expression": "fda_approved(drug_alpha)",
              "natural": "Drug Alpha is FDA-approved."
            }
          ],
          "conclusion": "G",
          "natural": "Influenza X is a global health priority."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule31",
              "prover9": "(-(A23 | (A22 -> (A15 -> A21))) -> A25)",
              "prover9_expression": "(-(traditional_approval_process(drug_alpha) | (regulatory_fast_track(drug_alpha) -> (pandemic_outbreak(influenza_x) -> distribution_network_activated(drug_alpha)))) -> patent_extended(drug_alpha))",
              "natural": "Whenever it is not the case that either drug Alpha is in the traditional approval process or, if regulatory fast track is in effect for drug Alpha, then under the condition that a pandemic outbreak of influenza X occurs, the distribution network is activated for drug Alpha, then drug Alpha's patent is extended."
            },
            {
              "id": "Rule11",
              "prover9": "(A25 -> A24)",
              "prover9_expression": "(patent_extended(drug_alpha) -> market_exclusivity_granted(drug_alpha))",
              "natural": "Whenever drug Alpha's patent is extended, then market exclusivity is granted for drug Alpha."
            }
          ],
          "conclusion": "(-(A23 | (A22 -> (A15 -> A21))) -> A24)",
          "natural": "If it is not the case that either drug Alpha is in the traditional approval process or, if regulatory fast track is in effect for drug Alpha, then provided a pandemic outbreak of influenza X happens, the distribution network is activated for drug Alpha, then market exclusivity is granted for drug Alpha."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A23 | (A22 -> (A15 -> A21))) -> A24)",
              "prover9_expression": "(-(traditional_approval_process(drug_alpha) | (regulatory_fast_track(drug_alpha) -> (pandemic_outbreak(influenza_x) -> distribution_network_activated(drug_alpha)))) -> market_exclusivity_granted(drug_alpha))",
              "natural": "If it is not the case that either drug Alpha is in the traditional approval process or, if regulatory fast track is in effect for drug Alpha, then provided a pandemic outbreak of influenza X happens, the distribution network is activated for drug Alpha, then market exclusivity is granted for drug Alpha."
            },
            {
              "id": "Rule32",
              "prover9": "(-(A23 | (A22 -> (A15 -> A21))) -> -A24)",
              "prover9_expression": "(-(traditional_approval_process(drug_alpha) | (regulatory_fast_track(drug_alpha) -> (pandemic_outbreak(influenza_x) -> distribution_network_activated(drug_alpha)))) -> -market_exclusivity_granted(drug_alpha))",
              "natural": "Provided that it is not the case that either drug Alpha is in the traditional approval process or, if regulatory fast track is in effect for drug Alpha, then whenever a pandemic outbreak of influenza X happens, the distribution network is activated for drug Alpha, then it is not the case that market exclusivity is granted for drug Alpha."
            }
          ],
          "conclusion": "(A23 | (A22 -> (A15 -> A21)))",
          "natural": "Either drug Alpha is in the traditional approval process or, if regulatory fast track is in effect for drug Alpha, then provided a pandemic outbreak of influenza X occurs, the distribution network is activated for drug Alpha."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A23 | (A22 -> (A15 -> A21)))",
              "prover9_expression": "(traditional_approval_process(drug_alpha) | (regulatory_fast_track(drug_alpha) -> (pandemic_outbreak(influenza_x) -> distribution_network_activated(drug_alpha))))",
              "natural": "Either drug Alpha is in the traditional approval process or, if regulatory fast track is in effect for drug Alpha, then provided a pandemic outbreak of influenza X occurs, the distribution network is activated for drug Alpha."
            },
            {
              "id": "Fact5",
              "prover9": "-A23",
              "prover9_expression": "-traditional_approval_process(drug_alpha)",
              "natural": "It is not the case that drug Alpha is in the traditional approval process."
            }
          ],
          "conclusion": "(A22 -> (A15 -> A21))",
          "natural": "If regulatory fast track is in effect for drug Alpha, then whenever a pandemic outbreak of influenza X happens, the distribution network is activated for drug Alpha."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A22 -> (A15 -> A21))",
              "prover9_expression": "(regulatory_fast_track(drug_alpha) -> (pandemic_outbreak(influenza_x) -> distribution_network_activated(drug_alpha)))",
              "natural": "If regulatory fast track is in effect for drug Alpha, then whenever a pandemic outbreak of influenza X happens, the distribution network is activated for drug Alpha."
            },
            {
              "id": "Fact1",
              "prover9": "A22",
              "prover9_expression": "regulatory_fast_track(drug_alpha)",
              "natural": "Drug Alpha is on regulatory fast track."
            }
          ],
          "conclusion": "(A15 -> A21)",
          "natural": "Whenever a pandemic outbreak of influenza X happens, then the distribution network is activated for drug Alpha."
        },
        {
          "step_number": 5,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A15 -> A21)",
              "prover9_expression": "(pandemic_outbreak(influenza_x) -> distribution_network_activated(drug_alpha))",
              "natural": "Whenever a pandemic outbreak of influenza X happens, then the distribution network is activated for drug Alpha."
            },
            {
              "id": "Rule10",
              "prover9": "(A21 -> A20)",
              "prover9_expression": "(distribution_network_activated(drug_alpha) -> mass_production_authorized(drug_alpha))",
              "natural": "Provided that the distribution network is activated for drug Alpha, then mass production is authorized for drug Alpha."
            }
          ],
          "conclusion": "(A15 -> A20)",
          "natural": "If a pandemic outbreak of influenza X occurs, then mass production is authorized for drug Alpha."
        },
        {
          "step_number": 6,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A15 -> A20)",
              "prover9_expression": "(pandemic_outbreak(influenza_x) -> mass_production_authorized(drug_alpha))",
              "natural": "If a pandemic outbreak of influenza X occurs, then mass production is authorized for drug Alpha."
            },
            {
              "id": "Rule9",
              "prover9": "(A20 -> A13)",
              "prover9_expression": "(mass_production_authorized(drug_alpha) -> production_scaled(drug_alpha))",
              "natural": "Under the condition that mass production is authorized for drug Alpha, then production is scaled for drug Alpha."
            }
          ],
          "conclusion": "(A15 -> A13)",
          "natural": "Provided that a pandemic outbreak of influenza X happens, then production is scaled for drug Alpha."
        },
        {
          "step_number": 7,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A15 -> A13)",
              "prover9_expression": "(pandemic_outbreak(influenza_x) -> production_scaled(drug_alpha))",
              "natural": "Provided that a pandemic outbreak of influenza X happens, then production is scaled for drug Alpha."
            },
            {
              "id": "Rule6",
              "prover9": "(A16 -> A14)",
              "prover9_expression": "(seasonal_outbreak(influenza_x) -> emergency_approval(drug_alpha))",
              "natural": "Under the condition that a seasonal outbreak occurs for influenza X, then emergency approval occurs for drug Alpha."
            },
            {
              "id": "Rule5",
              "prover9": "(A15 | A16)",
              "prover9_expression": "(pandemic_outbreak(influenza_x) | seasonal_outbreak(influenza_x))",
              "natural": "Either a pandemic outbreak happens for influenza X or a seasonal outbreak happens for influenza X."
            }
          ],
          "conclusion": "(A13 | A14)",
          "natural": "Either production is scaled for drug Alpha or emergency approval occurs for drug Alpha."
        },
        {
          "step_number": 8,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule3",
              "prover9": "(A13 -> A12)",
              "prover9_expression": "(production_scaled(drug_alpha) -> manufacturing_ready(drug_alpha))",
              "natural": "If production is scaled for drug Alpha, then manufacturing is ready for drug Alpha."
            },
            {
              "id": "Rule4",
              "prover9": "(A14 -> (A10 | A11))",
              "prover9_expression": "(emergency_approval(drug_alpha) -> (phase2_successful(drug_alpha) | phase3_successful(drug_alpha)))",
              "natural": "Under the condition that emergency approval occurs for drug Alpha, then either Phase 2 is successful for drug Alpha or Phase 3 is successful for drug Alpha."
            },
            {
              "id": "Derived",
              "prover9": "(A13 | A14)",
              "prover9_expression": "(production_scaled(drug_alpha) | emergency_approval(drug_alpha))",
              "natural": "Either production is scaled for drug Alpha or emergency approval occurs for drug Alpha."
            }
          ],
          "conclusion": "(A12 | (A10 | A11))",
          "natural": "Either manufacturing is ready for drug Alpha, or Phase 2 is successful for drug Alpha, or Phase 3 is successful for drug Alpha."
        },
        {
          "step_number": 9,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A12 | (A10 | A11))",
              "prover9_expression": "(manufacturing_ready(drug_alpha) | (phase2_successful(drug_alpha) | phase3_successful(drug_alpha)))",
              "natural": "Either manufacturing is ready for drug Alpha, or Phase 2 is successful for drug Alpha, or Phase 3 is successful for drug Alpha."
            },
            {
              "id": "Fact2",
              "prover9": "-A12",
              "prover9_expression": "-manufacturing_ready(drug_alpha)",
              "natural": "It is not the case that manufacturing is ready for drug Alpha."
            }
          ],
          "conclusion": "(A10 | A11)",
          "natural": "Either Phase 2 is successful for drug Alpha or Phase 3 is successful for drug Alpha."
        },
        {
          "step_number": 10,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A10 | A11)",
              "prover9_expression": "(phase2_successful(drug_alpha) | phase3_successful(drug_alpha))",
              "natural": "Either Phase 2 is successful for drug Alpha or Phase 3 is successful for drug Alpha."
            },
            {
              "id": "Rule1",
              "prover9": "(A10 -> A9)",
              "prover9_expression": "(phase2_successful(drug_alpha) -> fda_approved(drug_alpha))",
              "natural": "Provided that Phase 2 is successful for drug Alpha, then FDA approval for drug Alpha occurs."
            },
            {
              "id": "Rule2",
              "prover9": "(A11 -> A9)",
              "prover9_expression": "(phase3_successful(drug_alpha) -> fda_approved(drug_alpha))",
              "natural": "Whenever Phase 3 is successful for drug Alpha, then FDA approval for drug Alpha follows."
            }
          ],
          "conclusion": "A9",
          "natural": "Drug Alpha is FDA-approved."
        },
        {
          "step_number": 11,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule28",
              "prover9": "(A9 -> G)",
              "prover9_expression": "(fda_approved(drug_alpha) -> global_health_priority(influenza_x))",
              "natural": "If drug Alpha is FDA-approved, then influenza X is a global health priority."
            },
            {
              "id": "Derived",
              "prover9": "A9",
              "prover9_expression": "fda_approved(drug_alpha)",
              "natural": "Drug Alpha is FDA-approved."
            }
          ],
          "conclusion": "G",
          "natural": "Influenza X is a global health priority."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 5,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule18",
              "prover9": "(A30 -> A31)",
              "prover9_expression": "(clinical_failures(drug_alpha) -> statistical_significance_not_met(drug_alpha))",
              "natural": "Provided that drug Alpha has clinical failures, then statistical significance is not met for drug Alpha."
            },
            {
              "id": "Rule19",
              "prover9": "(A31 -> A28)",
              "prover9_expression": "(statistical_significance_not_met(drug_alpha) -> efficacy_concerns_raised(drug_alpha))",
              "natural": "If statistical significance is not met for drug Alpha, then efficacy concerns are raised for drug Alpha."
            }
          ],
          "conclusion": "(A30 -> A28)",
          "natural": "Whenever drug Alpha has clinical failures, then efficacy concerns are raised for drug Alpha."
        },
        {
          "step_number": 2,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule14",
              "prover9": "(A29 -> A27)",
              "prover9_expression": "(adverse_events_reported(drug_alpha) -> safety_concerns_raised(drug_alpha))",
              "natural": "Provided that adverse events are reported for drug Alpha, then safety concerns are raised for drug Alpha."
            },
            {
              "id": "Derived",
              "prover9": "(A30 -> A28)",
              "prover9_expression": "(clinical_failures(drug_alpha) -> efficacy_concerns_raised(drug_alpha))",
              "natural": "Whenever drug Alpha has clinical failures, then efficacy concerns are raised for drug Alpha."
            },
            {
              "id": "Rule15",
              "prover9": "(A29 | A30)",
              "prover9_expression": "(adverse_events_reported(drug_alpha) | clinical_failures(drug_alpha))",
              "natural": "Either adverse events are reported for drug Alpha or drug Alpha has clinical failures."
            }
          ],
          "conclusion": "(A27 | A28)",
          "natural": "Either safety concerns are raised for drug Alpha or efficacy concerns are raised for drug Alpha."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A27 | A28)",
              "prover9_expression": "(safety_concerns_raised(drug_alpha) | efficacy_concerns_raised(drug_alpha))",
              "natural": "Either safety concerns are raised for drug Alpha or efficacy concerns are raised for drug Alpha."
            },
            {
              "id": "Rule12",
              "prover9": "(A27 -> (-A9 -> A26))",
              "prover9_expression": "(safety_concerns_raised(drug_alpha) -> (-fda_approved(drug_alpha) -> treatment_restricted(drug_alpha)))",
              "natural": "Provided that safety concerns are raised for drug Alpha, then if it is not the case that drug Alpha is FDA-approved, then treatment is restricted for drug Alpha."
            },
            {
              "id": "Rule13",
              "prover9": "(A28 -> (-A9 -> A26))",
              "prover9_expression": "(efficacy_concerns_raised(drug_alpha) -> (-fda_approved(drug_alpha) -> treatment_restricted(drug_alpha)))",
              "natural": "If efficacy concerns are raised for drug Alpha, then under the condition that drug Alpha is not FDA-approved, then treatment is restricted for drug Alpha."
            }
          ],
          "conclusion": "(-A9 -> A26)",
          "natural": "If it is not the case that drug Alpha is FDA-approved, then treatment is restricted for drug Alpha."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-A9 -> A26)",
              "prover9_expression": "(-fda_approved(drug_alpha) -> treatment_restricted(drug_alpha))",
              "natural": "If it is not the case that drug Alpha is FDA-approved, then treatment is restricted for drug Alpha."
            },
            {
              "id": "Fact6",
              "prover9": "-A26",
              "prover9_expression": "-treatment_restricted(drug_alpha)",
              "natural": "Treatment is not restricted for drug Alpha."
            }
          ],
          "conclusion": "A9",
          "natural": "Drug Alpha is FDA-approved."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule28",
              "prover9": "(A9 -> G)",
              "prover9_expression": "(fda_approved(drug_alpha) -> global_health_priority(influenza_x))",
              "natural": "If drug Alpha is FDA-approved, then influenza X is a global health priority."
            },
            {
              "id": "Derived",
              "prover9": "A9",
              "prover9_expression": "fda_approved(drug_alpha)",
              "natural": "Drug Alpha is FDA-approved."
            }
          ],
          "conclusion": "G",
          "natural": "Influenza X is a global health priority."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule24",
              "prover9": "(A37 -> A38)",
              "prover9_expression": "(contradictory_evidence(drug_alpha) -> consensus_among_experts(drug_alpha))",
              "natural": "Under the condition that contradictory evidence exists for drug Alpha, then there is consensus among experts for drug Alpha."
            },
            {
              "id": "Rule25",
              "prover9": "(A37 -> -A38)",
              "prover9_expression": "(contradictory_evidence(drug_alpha) -> -consensus_among_experts(drug_alpha))",
              "natural": "If contradictory evidence exists for drug Alpha, then it is not the case that there is consensus among experts for drug Alpha."
            }
          ],
          "conclusion": "-A37",
          "natural": "Contradictory evidence does not exist for drug Alpha."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule26",
              "prover9": "(A37 | (A35 -> A34))",
              "prover9_expression": "(contradictory_evidence(drug_alpha) | (mortality_rate_high(influenza_x) -> public_health_need_high(influenza_x)))",
              "natural": "Either contradictory evidence exists for drug Alpha or, if influenza X has a high mortality rate, then public health need is high for influenza X."
            },
            {
              "id": "Derived",
              "prover9": "-A37",
              "prover9_expression": "-contradictory_evidence(drug_alpha)",
              "natural": "Contradictory evidence does not exist for drug Alpha."
            }
          ],
          "conclusion": "(A35 -> A34)",
          "natural": "If influenza X has a high mortality rate, then public health need is high for influenza X."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule22",
              "prover9": "(A35 | A36)",
              "prover9_expression": "(mortality_rate_high(influenza_x) | transmission_rate_high(influenza_x))",
              "natural": "Either influenza X has a high mortality rate or influenza X has a high transmission rate."
            },
            {
              "id": "Derived",
              "prover9": "(A35 -> A34)",
              "prover9_expression": "(mortality_rate_high(influenza_x) -> public_health_need_high(influenza_x))",
              "natural": "If influenza X has a high mortality rate, then public health need is high for influenza X."
            },
            {
              "id": "Rule23",
              "prover9": "(A36 -> A34)",
              "prover9_expression": "(transmission_rate_high(influenza_x) -> public_health_need_high(influenza_x))",
              "natural": "Provided that influenza X has a high transmission rate, then public health need is high for influenza X."
            }
          ],
          "conclusion": "A34",
          "natural": "Public health need for influenza X is high."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule21",
              "prover9": "(A34 -> (-(A17 -> (A15 -> A13)) -> A33))",
              "prover9_expression": "(public_health_need_high(influenza_x) -> (-(who_declares_emergency(influenza_x) -> (pandemic_outbreak(influenza_x) -> production_scaled(drug_alpha))) -> competitor_drugs_exist(drug_alpha)))",
              "natural": "Provided that public health need is high for influenza X, then if it is not the case that when WHO declares an emergency for influenza X, then if a pandemic outbreak of influenza X happens, production is scaled for drug Alpha, then competitor drugs exist for drug Alpha."
            },
            {
              "id": "Derived",
              "prover9": "A34",
              "prover9_expression": "public_health_need_high(influenza_x)",
              "natural": "Public health need for influenza X is high."
            }
          ],
          "conclusion": "(-(A17 -> (A15 -> A13)) -> A33)",
          "natural": "Under the condition that it is not the case that whenever WHO declares an emergency for influenza X, then if a pandemic outbreak of influenza X happens, production is scaled for drug Alpha, then competitor drugs exist for drug Alpha."
        },
        {
          "step_number": 5,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A17 -> (A15 -> A13)) -> A33)",
              "prover9_expression": "(-(who_declares_emergency(influenza_x) -> (pandemic_outbreak(influenza_x) -> production_scaled(drug_alpha))) -> competitor_drugs_exist(drug_alpha))",
              "natural": "Under the condition that it is not the case that whenever WHO declares an emergency for influenza X, then if a pandemic outbreak of influenza X happens, production is scaled for drug Alpha, then competitor drugs exist for drug Alpha."
            },
            {
              "id": "Rule20",
              "prover9": "(A33 -> A32)",
              "prover9_expression": "(competitor_drugs_exist(drug_alpha) -> alternative_therapies_available(drug_alpha))",
              "natural": "Under the condition that competitor drugs exist for drug Alpha, then alternative therapies are available for drug Alpha."
            }
          ],
          "conclusion": "(-(A17 -> (A15 -> A13)) -> A32)",
          "natural": "If it is not the case that when WHO declares an emergency for influenza X, then provided a pandemic outbreak of influenza X occurs, production is scaled for drug Alpha, then alternative therapies are available for drug Alpha."
        },
        {
          "step_number": 6,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A17 -> (A15 -> A13)) -> A32)",
              "prover9_expression": "(-(who_declares_emergency(influenza_x) -> (pandemic_outbreak(influenza_x) -> production_scaled(drug_alpha))) -> alternative_therapies_available(drug_alpha))",
              "natural": "If it is not the case that when WHO declares an emergency for influenza X, then provided a pandemic outbreak of influenza X occurs, production is scaled for drug Alpha, then alternative therapies are available for drug Alpha."
            },
            {
              "id": "Rule30",
              "prover9": "(-(A17 -> (A15 -> A13)) -> -A32)",
              "prover9_expression": "(-(who_declares_emergency(influenza_x) -> (pandemic_outbreak(influenza_x) -> production_scaled(drug_alpha))) -> -alternative_therapies_available(drug_alpha))",
              "natural": "Provided that it is not the case that when WHO declares an emergency for influenza X, then under the condition that a pandemic outbreak of influenza X occurs, production is scaled for drug Alpha, then it is not the case that alternative therapies are available for drug Alpha."
            }
          ],
          "conclusion": "(A17 -> (A15 -> A13))",
          "natural": "Provided that WHO declares an emergency for influenza X, then if a pandemic outbreak of influenza X happens, production is scaled for drug Alpha."
        },
        {
          "step_number": 7,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule7",
              "prover9": "(A17 | A18)",
              "prover9_expression": "(who_declares_emergency(influenza_x) | cdc_declares_emergency(influenza_x))",
              "natural": "Either WHO declares an emergency for influenza X or CDC declares an emergency for influenza X."
            },
            {
              "id": "Derived",
              "prover9": "(A17 -> (A15 -> A13))",
              "prover9_expression": "(who_declares_emergency(influenza_x) -> (pandemic_outbreak(influenza_x) -> production_scaled(drug_alpha)))",
              "natural": "Provided that WHO declares an emergency for influenza X, then if a pandemic outbreak of influenza X happens, production is scaled for drug Alpha."
            },
            {
              "id": "Rule8",
              "prover9": "(A18 -> (A15 -> A13))",
              "prover9_expression": "(cdc_declares_emergency(influenza_x) -> (pandemic_outbreak(influenza_x) -> production_scaled(drug_alpha)))",
              "natural": "If CDC declares an emergency for influenza X, then whenever a pandemic outbreak of influenza X occurs, production is scaled for drug Alpha."
            }
          ],
          "conclusion": "(A15 -> A13)",
          "natural": "Provided that a pandemic outbreak of influenza X happens, then production is scaled for drug Alpha."
        },
        {
          "step_number": 8,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A15 -> A13)",
              "prover9_expression": "(pandemic_outbreak(influenza_x) -> production_scaled(drug_alpha))",
              "natural": "Provided that a pandemic outbreak of influenza X happens, then production is scaled for drug Alpha."
            },
            {
              "id": "Rule6",
              "prover9": "(A16 -> A14)",
              "prover9_expression": "(seasonal_outbreak(influenza_x) -> emergency_approval(drug_alpha))",
              "natural": "Under the condition that a seasonal outbreak occurs for influenza X, then emergency approval occurs for drug Alpha."
            },
            {
              "id": "Rule5",
              "prover9": "(A15 | A16)",
              "prover9_expression": "(pandemic_outbreak(influenza_x) | seasonal_outbreak(influenza_x))",
              "natural": "Either a pandemic outbreak happens for influenza X or a seasonal outbreak happens for influenza X."
            }
          ],
          "conclusion": "(A13 | A14)",
          "natural": "Either production is scaled for drug Alpha or emergency approval occurs for drug Alpha."
        },
        {
          "step_number": 9,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule3",
              "prover9": "(A13 -> A12)",
              "prover9_expression": "(production_scaled(drug_alpha) -> manufacturing_ready(drug_alpha))",
              "natural": "If production is scaled for drug Alpha, then manufacturing is ready for drug Alpha."
            },
            {
              "id": "Rule4",
              "prover9": "(A14 -> (A10 | A11))",
              "prover9_expression": "(emergency_approval(drug_alpha) -> (phase2_successful(drug_alpha) | phase3_successful(drug_alpha)))",
              "natural": "Under the condition that emergency approval occurs for drug Alpha, then either Phase 2 is successful for drug Alpha or Phase 3 is successful for drug Alpha."
            },
            {
              "id": "Derived",
              "prover9": "(A13 | A14)",
              "prover9_expression": "(production_scaled(drug_alpha) | emergency_approval(drug_alpha))",
              "natural": "Either production is scaled for drug Alpha or emergency approval occurs for drug Alpha."
            }
          ],
          "conclusion": "(A12 | (A10 | A11))",
          "natural": "Either manufacturing is ready for drug Alpha, or Phase 2 is successful for drug Alpha, or Phase 3 is successful for drug Alpha."
        },
        {
          "step_number": 10,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A12 | (A10 | A11))",
              "prover9_expression": "(manufacturing_ready(drug_alpha) | (phase2_successful(drug_alpha) | phase3_successful(drug_alpha)))",
              "natural": "Either manufacturing is ready for drug Alpha, or Phase 2 is successful for drug Alpha, or Phase 3 is successful for drug Alpha."
            },
            {
              "id": "Fact2",
              "prover9": "-A12",
              "prover9_expression": "-manufacturing_ready(drug_alpha)",
              "natural": "It is not the case that manufacturing is ready for drug Alpha."
            }
          ],
          "conclusion": "(A10 | A11)",
          "natural": "Either Phase 2 is successful for drug Alpha or Phase 3 is successful for drug Alpha."
        },
        {
          "step_number": 11,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A10 | A11)",
              "prover9_expression": "(phase2_successful(drug_alpha) | phase3_successful(drug_alpha))",
              "natural": "Either Phase 2 is successful for drug Alpha or Phase 3 is successful for drug Alpha."
            },
            {
              "id": "Rule1",
              "prover9": "(A10 -> A9)",
              "prover9_expression": "(phase2_successful(drug_alpha) -> fda_approved(drug_alpha))",
              "natural": "Provided that Phase 2 is successful for drug Alpha, then FDA approval for drug Alpha occurs."
            },
            {
              "id": "Rule2",
              "prover9": "(A11 -> A9)",
              "prover9_expression": "(phase3_successful(drug_alpha) -> fda_approved(drug_alpha))",
              "natural": "Whenever Phase 3 is successful for drug Alpha, then FDA approval for drug Alpha follows."
            }
          ],
          "conclusion": "A9",
          "natural": "Drug Alpha is FDA-approved."
        },
        {
          "step_number": 12,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule28",
              "prover9": "(A9 -> G)",
              "prover9_expression": "(fda_approved(drug_alpha) -> global_health_priority(influenza_x))",
              "natural": "If drug Alpha is FDA-approved, then influenza X is a global health priority."
            },
            {
              "id": "Derived",
              "prover9": "A9",
              "prover9_expression": "fda_approved(drug_alpha)",
              "natural": "Drug Alpha is FDA-approved."
            }
          ],
          "conclusion": "G",
          "natural": "Influenza X is a global health priority."
        }
      ]
    }
  ]
}